Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease.

Overview of attention for article published in Advances in Clinical and Experimental Medicine, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 642)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 11,828 followers.

Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease (Sept 2023) https://t.co/7IQwePdQhR https://t.co/GDcpASQxC7

@terrakei07 レカネマブは『アルツハイマー病のリスクの高い女性やAPOEキャリアには無効・或いは悪化することもあるので有効性が低い』『FDA最悪の認可』と主張する論文もありますな🤔 https://t.co/XeSuRUaN1B

RT @syuichiao89: レカネマブ（レケンビ）はアルツハイマー病患者にとって適切な薬ではない……という論考が💦 https://t.co/ibHJRlPFyz https://t.co/W6dQUzQQVY

RT @syuichiao89: レカネマブ（レケンビ）はアルツハイマー病患者にとって適切な薬ではない……という論考が💦 https://t.co/ibHJRlPFyz https://t.co/W6dQUzQQVY

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.